Differential cellular immunolocalization of renal tumour necrosis factor-alpha production during ischaemia versus endotoxaemia.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 1783149)

Published in Immunology on January 01, 2001

Authors

K K Donnahoo1, X Meng, L Ao, A Ayala, B D Shames, M P Cain, A H Harken, D R Meldrum

Author Affiliations

1: Department of Urology, Indiana University Medical Center, Indianapolis, IN.

Articles cited by this

Function and activation of NF-kappa B in the immune system. Annu Rev Immunol (1994) 17.04

Shock and tissue injury induced by recombinant human cachectin. Science (1986) 16.24

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature (1988) 13.42

A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature (1995) 11.89

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med (1986) 10.91

Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem (1998) 5.99

Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med (1998) 4.12

Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J Biol Chem (1996) 3.65

Tumor necrosis factor in the heart. Am J Physiol (1998) 3.45

Endotoxin signal transduction in macrophages. J Leukoc Biol (1996) 3.05

The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J Clin Invest (1997) 2.28

Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis. J Immunol (1988) 2.13

Endotoxin induces rapid protein tyrosine phosphorylation in 70Z/3 cells expressing CD14. J Biol Chem (1993) 1.93

Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J Biol Chem (1997) 1.84

Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats. Lab Invest (1994) 1.84

Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol (1992) 1.80

Tumor necrosis factor and IL-1 in New Zealand Black/White mice. Enhanced gene expression and acceleration of renal injury. J Immunol (1989) 1.65

Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am J Physiol (1999) 1.64

CD28-b7 blockade in organ dysfunction secondary to cold ischemia/reperfusion injury. Kidney Int (1997) 1.57

Interleukin 1-alpha and tumor necrosis factor-alpha induce oxygen radical production in mesangial cells. Kidney Int (1990) 1.57

Production of tumor necrosis factor by rat mesangial cells in response to bacterial lipopolysaccharide. Kidney Int (1989) 1.56

Tumor necrosis factor induces glomerular damage in the rabbit. Am J Pathol (1989) 1.51

Review article: the role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol (1999) 1.48

Hemorrhage activates myocardial NFkappaB and increases TNF-alpha in the heart. J Mol Cell Cardiol (1997) 1.31

Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin. Cytokine (1990) 1.30

mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes (1993) 1.26

The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J Clin Invest (1992) 1.22

Tissue remodeling during tumor necrosis factor-induced apoptosis in LLC-PK1 renal epithelial cells. Am J Physiol (1996) 1.21

Activation of multiple proline-directed kinases by bacterial lipopolysaccharide in murine macrophages. J Immunol (1996) 1.20

Requirements for tumor necrosis factor-alpha and interleukin-1 in limb ischemia/reperfusion injury and associated lung injury. Am J Pathol (1993) 1.17

Continuous in situ cold perfusion with histidine tryptophan ketoglutarate solution in nephron sparing surgery for renal tumors. J Urol (1995) 1.16

Neutrophils, monocytes, and lymphocytes bind to cytokine-activated kidney glomerular endothelial cells through L-selectin (LAM-1) in vitro. J Immunol (1992) 1.15

Stimulation of c-Jun kinase and mitogen-activated protein kinase by ischemia and reperfusion in the perfused rat heart. Biochem Biophys Res Commun (1996) 1.13

Modulation of tumor necrosis factor-induced increase in renal (LLC-PK1) transepithelial permeability. Am J Physiol (1992) 1.12

Necrosis and apoptosis in acute renal failure. Semin Nephrol (1998) 1.11

Hemorrhage induces enhanced Kupffer cell cytotoxicity while decreasing peritoneal or splenic macrophage capacity. Involvement of cell-associated tumor necrosis factor and reactive nitrogen. J Immunol (1991) 1.11

Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney. Transplantation (1997) 1.07

Prevention of late renal changes after initial ischemia/reperfusion injury by blocking early selectin binding. Transplantation (1997) 1.04

Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion. J Am Coll Cardiol (1996) 1.03

Tumor necrosis factor stimulates prostaglandin production and cyclic AMP levels in rat cultured mesangial cells. FEBS Lett (1988) 1.02

Glomerular tumor necrosis factor and interleukin 1 during acute aminonucleoside nephrosis. An immunohistochemical study. Lab Invest (1991) 1.01

Hydrogen peroxide induces tumor necrosis factor alpha-mediated cardiac injury by a P38 mitogen-activated protein kinase-dependent mechanism. Surgery (1998) 0.96

LPS-induced MCP-1, IL-1 beta, and TNF-alpha mRNA expression in isolated erythrocyte-perfused rat kidney. Am J Physiol (1993) 0.93

Tumor necrosis factor in renal injury. Miner Electrolyte Metab (1995) 0.92

The impact of complications after vascular surgery in Veterans Affairs Medical Centers. J Surg Res (1997) 0.89

Protective effect of exogenous nitric oxide on the renal function and inflammatory response in a model of ischemia-reperfusion. Transplantation (1998) 0.87

Cytokine formation within rat glomeruli during experimental endotoxemia. J Am Soc Nephrol (1993) 0.85

Hypoxia induces intercellular adhesion molecule-1 on cultured human tubular cells. Kidney Int (1997) 0.85

Effect of leukocyte stimulation on rabbit immune complex glomerulonephritis. Kidney Int (1990) 0.84

The immunocytochemical localization of tumour necrosis factor and leukotriene in the rat kidney after treatment with lipopolysaccharide. Int J Exp Pathol (1993) 0.83

Role of endothelin and tumour necrosis factor in the renal response to sepsis. Nephrol Dial Transplant (1994) 0.77

Articles by these authors

Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science (1997) 6.37

Mating type switching in yeast controlled by asymmetric localization of ASH1 mRNA. Science (1997) 4.23

Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function. Crit Care Med (1999) 2.63

A conserved p38 mitogen-activated protein kinase pathway regulates Drosophila immunity gene expression. Mol Cell Biol (1998) 2.57

Blastocyst culture and transfer: analysis of results and parameters affecting outcome in two in vitro fertilization programs. Fertil Steril (1999) 2.52

Little emperors: behavioral impacts of China's One-Child Policy. Science (2013) 2.37

Effect of gender and sex hormones on immune responses following shock. Shock (2000) 2.37

Treatment of primary osteosarcoma with intra-arterial and intravenous high-dose methotrexate. J Clin Oncol (1983) 2.35

Biologic effects of transdermal estradiol. N Engl J Med (1986) 2.24

Mouse suppressor of fused is a negative regulator of sonic hedgehog signaling and alters the subcellular distribution of Gli1. Curr Biol (1999) 2.12

Glial-cell-line-derived neurotrophic factor is required for bud initiation from ureteric epithelium. Development (1997) 2.05

Clinical L-type Ca(2+) channel blockade prevents ischemic preconditioning of human myocardium. J Mol Cell Cardiol (1999) 2.04

Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1beta. Proc Natl Acad Sci U S A (2001) 1.97

Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. Crit Care Med (1997) 1.83

A giant outburst two years before the core-collapse of a massive star. Nature (2007) 1.82

cDNA-derived amino acid sequence of the 86-kDa subunit of the Ku antigen. J Biol Chem (1989) 1.81

Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited. Circulation (1997) 1.80

The abdominal compartment syndrome is a morbid complication of postinjury damage control surgery. Am J Surg (2001) 1.76

Prevalence of human respiratory viruses in adults with acute respiratory tract infections in Beijing, 2005-2007. Clin Microbiol Infect (2009) 1.76

Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am J Physiol (1999) 1.64

Evidence favoring the role of the gut as a cytokine-generating organ in rats subjected to hemorrhagic shock. Shock (1994) 1.61

Cornual pregnancies in patients with prior salpingectomy undergoing in vitro fertilization and embryo transfer. Fertil Steril (1996) 1.60

Effects of hydroxyethyl starch after trauma-hemorrhagic shock: restoration of macrophage integrity and prevention of increased circulating interleukin-6 levels. Crit Care Med (1995) 1.59

An exclusively nuclear RNA-binding protein affects asymmetric localization of ASH1 mRNA and Ash1p in yeast. J Cell Biol (2001) 1.58

"Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis. J Clin Endocrinol Metab (1982) 1.57

The physiologic basis for anticytokine clinical trials in the treatment of sepsis. J Am Coll Surg (1998) 1.57

Severe depression of host immune functions following closed-bone fracture, soft-tissue trauma, and hemorrhagic shock. Crit Care Med (1998) 1.56

Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study. Clin Orthop Relat Res (1991) 1.56

Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56

Effects of trauma, duration of hypotension, and resuscitation regimen on cellular immunity after hemorrhagic shock. Crit Care Med (1994) 1.53

Anti-antivivisection. Have we waited too long? Arch Surg (1989) 1.53

Tumor necrosis factor-alpha produces hepatocellular dysfunction despite normal cardiac output and hepatic microcirculation. Am J Physiol (1993) 1.50

Stress increases vulnerability to inflammation in the rat prefrontal cortex. J Neurosci (2006) 1.50

Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat hearts. Proc Natl Acad Sci U S A (1989) 1.50

The complex pattern of cytokines in sepsis. Association between prostaglandins, cachectin, and interleukins. Ann Surg (1991) 1.48

Review article: the role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol (1999) 1.48

A novel human gene, WSTF, is deleted in Williams syndrome. Genomics (1998) 1.47

Feasibility of damage control surgery in the management of military combat casualties. Arch Surg (2000) 1.45

Endocardial excision: a new surgical technique for the treatment of recurrent ventricular tachycardia. Circulation (1979) 1.43

Skin reactions at the application site of rivastigmine patch (4.6 mg/24 h, 9.5 mg/24 h or 13.3 mg/24 h): a qualitative analysis of clinical studies in patients with Alzheimer's disease. Int J Clin Pract (2015) 1.43

Response to Slotnich and ortega [Monoamniotic twinning and zone manipulation: a survey of U.S. IVF centers correlating zona manipulation procedures and high-risk twinning frequency (J Assist Reprod Genet 1996; 13:381-385)]. J Assist Reprod Genet (1996) 1.39

Potential gene therapy strategies in the treatment of cardiovascular disease. Ann Thorac Surg (1995) 1.39

Effect of naloxone on immune responses after hemorrhagic shock. Crit Care Med (2000) 1.39

Sorting nexin 6, a novel SNX, interacts with the transforming growth factor-beta family of receptor serine-threonine kinases. J Biol Chem (2001) 1.38

Diastolic hibernation masquerading as constrictive pericarditis. J Card Surg (1998) 1.38

Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent. Med Hypotheses (1995) 1.36

Thirty years of clinical trials in acute respiratory distress syndrome. Crit Care Med (2000) 1.36

Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist. J Clin Endocrinol Metab (1983) 1.36

Melatonin administration following hemorrhagic shock decreases mortality from subsequent septic challenge. J Surg Res (1996) 1.35

Preconditioning against myocardial dysfunction after ischemia and reperfusion by an alpha 1-adrenergic mechanism. Circ Res (1993) 1.35

Partial splenic embolization for hypersplenism in cirrhosis: a long-term outcome in 62 patients. Dig Liver Dis (2008) 1.35

Estrogen levels in postmenopausal women with hot flashes. Obstet Gynecol (1982) 1.35

TNF-alpha mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling. Am J Physiol Renal Physiol (2004) 1.33

N-acetyl-cysteine decreases the matrix-degrading capacity of macrophage-derived foam cells: new target for antioxidant therapy? Circulation (1998) 1.33

A novel smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-beta signal transduction. Genes Dev (2000) 1.32

Hemorrhage activates myocardial NFkappaB and increases TNF-alpha in the heart. J Mol Cell Cardiol (1997) 1.31

Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin. Cytokine (1990) 1.30

Testosterone receptor blockade after hemorrhage in males. Restoration of the depressed immune functions and improved survival following subsequent sepsis. Arch Surg (1997) 1.30

Epithelial apoptosis in mechanistically distinct methods of injury in the murine small intestine. Histol Histopathol (2007) 1.29

Xanthine oxidase produces hydrogen peroxide which contributes to reperfusion injury of ischemic, isolated, perfused rat hearts. J Clin Invest (1988) 1.29

Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chem Res Toxicol (2000) 1.28

Is Fas ligand or endotoxin responsible for mucosal lymphocyte apoptosis in sepsis? Arch Surg (1998) 1.26

Ventricular resection guided by epicardial and endocardial mapping for treatment of recurrent ventricular tachycardia. N Engl J Med (1980) 1.26

An improved method for the determination of green and black tea polyphenols in biomatrices by high-performance liquid chromatography with coulometric array detection. Anal Biochem (2000) 1.26

Upregulation of aquaporin-2 water channel expression in chronic heart failure rat. J Clin Invest (1997) 1.25

Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res (1995) 1.25

Relationship of fasting urinary calcium to circulating estrogen and body weight in postmenopausal women. J Clin Endocrinol Metab (1980) 1.25

Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7  TeV. Phys Rev Lett (2012) 1.23

The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure. Surg Gynecol Obstet (1991) 1.23

Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure-activity relationship and mechanisms involved. Cancer Res (1999) 1.22

Enhanced immune responses in females, as opposed to decreased responses in males following haemorrhagic shock and resuscitation. Cytokine (1996) 1.21

The loss of Mcl-1 expression in human polymorphonuclear leukocytes promotes apoptosis. J Leukoc Biol (2000) 1.21

Osteosarcoma in preadolescent patients. Clin Orthop Relat Res (2000) 1.20

Interleukin 1 pretreatment decreases ischemia/reperfusion injury. Proc Natl Acad Sci U S A (1990) 1.20

Hemorrhage and resuscitation: immunological aspects. Am J Physiol (1990) 1.20

Sex steroids regulate pro- and anti-inflammatory cytokine release by macrophages after trauma-hemorrhage. Am J Physiol (1999) 1.19

Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19

Low-grade (fibromatosis-like) spindle cell carcinoma of the breast. Am J Surg Pathol (2001) 1.19

Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76  TeV. Phys Rev Lett (2012) 1.19

The incidence of prostate cancer in a screening population with a serum prostate specific antigen between 2.5 and 4.0 ng/ml: relation to biopsy strategy. J Urol (2001) 1.18

Mechanism of immunosuppression in males following trauma-hemorrhage. Critical role of testosterone. Arch Surg (1996) 1.17

What is the role of interleukin 10 in polymicrobial sepsis: anti-inflammatory agent or immunosuppressant? Surgery (1999) 1.17

Abnormal expression of hepatoma specific gamma-glutamyl transferase and alteration of gamma-glutamyl transferase gene methylation status in patients with hepatocellular carcinoma. Cancer (2000) 1.17

Early renal ischemia, with or without reperfusion, activates NFkappaB and increases TNF-alpha bioactivity in the kidney. J Urol (2000) 1.16